Cite
HARVARD Citation
Carracedo, M. et al. (2022). The tyrosine kinase inhibitor nilotinib targets the discoidin domain receptor DDR2 in calcific aortic valve stenosis. British journal of pharmacology. pp. 4709-4721. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Carracedo, M. et al. (2022). The tyrosine kinase inhibitor nilotinib targets the discoidin domain receptor DDR2 in calcific aortic valve stenosis. British journal of pharmacology. pp. 4709-4721. [Online].